DGAP-Adhoc: Balda AG: Management Board and Supervisory Board support the Offer of the Italian Stevanato Group in the amount of EUR 80 million regarding the purchase of the entire operating business – Extraordinary General Meeting probably at the end of January 2016
15.12.2015
Balda AG / Key word(s): Disposal
15.12.2015 15:47
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
—————————————————————————
Bad Oeynhausen, 15 December 2015 – As announced in an ad hoc announcement
yesterday, Balda AG received a binding offer by the Italian Stevanato Group
(“Stevanato”) regarding the sale of its entire operating business at a
purchase price of EUR 80 million on 14 December 2015.
The Annual General Meeting of Balda AG had already approved a binding offer
by the Heitkamp & Thumann Group, Düsseldorf (“H&T”), concerning the sale of
its entire operating business at a purchase price of EUR 74 million on 30
November / 1 December 2015. Balda AG so far has not accepted this offer.
The offer by Stevanato also comprises the sale of all operating units of
the Balda Group, namely Balda Medical GmbH & Co. KG, Balda C. Brewer, Inc.
and Balda Precision, Inc., both located in California, USA, as well as
Balda Medical Systems SRL, Romania, and further assets. Moreover, Stevanato
also offers to keep all employees of the operating units and take over
staff of Balda AG. Contrary to H&T, Stevanato intends to also purchase the
“Balda” brand and any associated (intangible) assets. The offer by
Stevanato is also subject to prior approval by the General Meeting of Balda
AG.
Meanwhile, the Management Board and the Supervisory Board have reviewed the
offer by Stevanato in detail and, taking all facts into account, regard the
offer by Stevanato preferable to the offer by H&T. In the next days, the
Management Board will convene an extraordinary General Meeting which will
presumably take place on 29 January 2016 in Hannover. At this extraordinary
General Meeting, the offer by Stevanato will be submitted to the General
Meeting for approval.
Contact / Contact Person:
Michael Pfister
Deekeling Arndt Advisors
tel: +49 (0) 5734 922 2555
moble: +49 (0) 160 90560506
email: michael.pfister@deekeling-arndt.de
About Balda
Balda (ISIN: DE0005215107) is a provider of high-end plastics solutions
that rely on quality in sophisticated fields of application in the
healthcare, lifestyle, automotive and consumer electronics industry. Balda
operates in Europe and Northern America and has state of the art production
sites at the Oeynhausen headquarters in Germany and in the US. The
company’s success with its about 800 staff worldwide is based on the use of
modern, cost-efficient technologies and the close cooperation with our
customers in a spirit of trust.
www.balda-group.com
15.12.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
—————————————————————————
Language: English
Company: Balda AG
Bergkirchener Str. 228
32549 Bad Oeynhausen
Germany
Phone: +49 (0) 57 34 / 9 22-0
Fax: +49 (0) 57 34 / 9 22-2604
E-mail: ir@balda-group.com
Internet: www.balda-group.com
ISIN: DE0005215107
WKN: 521510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart
End of Announcement DGAP News-Service
—————————————————————————